We tested and scored the leading online medical weight loss programs — comparing GLP-1 medication options, pricing transparency, clinical oversight, and ongoing support — so you can choose with confidence.
Ranked by our editorial team on effectiveness, speed, value, clinical oversight, and patient experience. Scores are out of 10.
Name-brand and compounded GLP-1 options with coaching built into every plan.
Compounded GLP-1 from $149/mo with a lifetime price lock at every dose.
Low-cost compounded semaglutide and tirzepatide with 24-hour online approval.
Semaglutide plans from $89/mo with lifetime locked-in pricing.
Clinically dosed compounded semaglutide with round-the-clock medical support.
Semaglutide and tirzepatide with no membership fees and no contracts.
Aggressively priced GLP-1 program with fully online visits and free 2-day delivery.
Medical weight loss is physician-supervised treatment that combines prescription medication with clinical monitoring and, on the better platforms, lifestyle coaching. The current generation of programs centers on GLP-1 receptor agonists — medications like semaglutide and tirzepatide — which have shifted average results from the 3–5% body weight loss typical of diet-only approaches to 15% or more in clinical trials.
Online programs deliver this care through telehealth: you complete a medical intake, a licensed clinician reviews your history, and if you qualify, medication ships to your door with ongoing check-ins. Some providers dispense FDA-approved brand-name products (Wegovy, Zepbound, Ozempic), while many offer compounded versions of the same active ingredients at a substantially lower cash price.
Eligibility follows established medical criteria rather than personal preference. A licensed clinician makes the final call based on your full health picture, but most programs prescribe GLP-1 therapy for adults who meet at least one of the following:
Pregnant or breastfeeding women, and people with certain gastrointestinal or endocrine conditions, are generally not candidates. An honest intake protects you here — the questionnaire is how the prescribing clinician screens for safety.
GLP-1 medications mimic a natural gut hormone (glucagon-like peptide-1) that regulates appetite and blood sugar. They slow stomach emptying so you feel full sooner and longer, quiet the food-focused signaling in the brain that many patients describe as constant "food noise," and improve insulin response. Tirzepatide adds a second hormone pathway (GIP), which is why it posts the highest average weight loss in head-to-head data.
Medication is only one lever, though. Sustainable results come from how the medication, your habits, and your underlying metabolism work together:
This is why programs that bundle coaching and clinician check-ins tend to outperform bare-prescription models — dose titration, side-effect management, and habit support all affect whether the weight stays off.
Here is how the main treatment paths compare. A licensed provider will help you choose based on your health history, goals, and budget.
| Option | Examples | How it's taken | Typical weight loss | Best for |
|---|---|---|---|---|
| Semaglutide (GLP-1) | Wegovy, Ozempic, compounded | Weekly injection | ~15% of body weight | Proven first-line choice |
| Tirzepatide (GLP-1/GIP) | Zepbound, Mounjaro, compounded | Weekly injection | Up to ~20% | Highest average results |
| Oral GLP-1 | Wegovy pill (oral semaglutide) | Daily pill | ~10–15% | Needle-free preference |
| Lifestyle only | Diet, exercise, coaching | Daily habits | ~3–5% | Modest goals, medication-averse |
Important: GLP-1 medications commonly cause nausea and digestive side effects, especially during dose increases, and are not appropriate for people with a personal or family history of medullary thyroid cancer or MEN2. Compounded semaglutide and tirzepatide are not FDA-approved finished products. Always complete an honest medical intake and never use medication prescribed to someone else.
Reputable telehealth weight loss programs are a legitimate, medically supervised way to access GLP-1 therapy. The good ones connect you with US-licensed clinicians, require a real medical review before prescribing, source medication from licensed (ideally LegitScript-certified) US pharmacies, and provide ongoing monitoring as your dose is adjusted. For compounded medication, third-party testing of each batch is a meaningful quality signal worth asking about.
The red flags are the same as in any telehealth category: sites that sell injectables with no questionnaire or clinician involvement, prices dramatically below the legitimate market, unverifiable pharmacy sourcing, or "research use" peptides marketed for weight loss. If a platform won't tell you which pharmacy fills your prescription or who reviews your intake, choose one that will.
Most programs follow the same simple, fully remote flow:
Most people start at a low dose that increases gradually over the first weeks, with noticeable appetite changes early and steady weight loss building over months. Compare our top-rated programs above to find the right fit for your budget and goals.
Our highest-scoring picks, with the honest pros and cons our editorial team noted during testing.
9.9 Shed pairs both brand-name and compounded GLP-1 medication with continuous coaching on one platform — our overall pick for people who want more than a prescription.
9.6 TrimRx locks in your rate for life, so the price stays the same as your dose increases — a rare guarantee in a market where costs often climb during titration.
9.5 Yucca Health offers some of the lowest legitimate compounded GLP-1 pricing we found, with approval typically inside 24 hours and no clinic visits required.
Learn more about how American Health Reviews rankings are determined — our scoring weighs effectiveness, pricing, clinical oversight, speed, and patient experience.
Read MoreSemaglutide mimics GLP-1, a gut hormone that regulates appetite and blood sugar. It slows stomach emptying so you feel full longer, reduces hunger signaling in the brain, and improves insulin response. The practical effect most patients report is simply eating less without the constant effort of willpower.
Most programs follow standard clinical criteria: a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea. A licensed clinician makes the final decision after reviewing your full health history during the online intake.
Semaglutide activates one hormone pathway (GLP-1), while tirzepatide activates two (GLP-1 and GIP). In clinical trials, tirzepatide has produced higher average weight loss — up to around 20% of body weight versus roughly 15% for semaglutide. Tirzepatide typically costs more, and both are taken as a once-weekly injection.
Compounded semaglutide and tirzepatide contain the same active ingredients as the brand-name products but are prepared by compounding pharmacies and are not FDA-approved finished drugs. Quality depends on the pharmacy: look for programs that use licensed, US-based, LegitScript-certified pharmacies with third-party testing. Avoid any source that skips a medical review.
Nausea is the most common side effect, especially in the first weeks and after dose increases. Constipation, diarrhea, fatigue, and injection-site irritation also occur. Most effects fade as your body adjusts, and slow dose titration helps. Severe abdominal pain, vomiting that won't stop, or signs of pancreatitis warrant immediate medical attention.
Appetite changes often show up within the first one to two weeks, with measurable weight loss typically starting in the first month. Clinically meaningful results build over several months as your dose reaches its maintenance level — trials generally measure peak results at the 12–17 month mark.
Sometimes — coverage for brand-name products like Wegovy and Zepbound varies widely by plan, and many plans exclude weight loss medication entirely. Most of the telehealth programs we ranked use a direct-pay model and don't bill insurance, though several are HSA/FSA eligible, which lets you pay with pre-tax dollars.
Compounded semaglutide programs on this list start between $89 and $149 per month, with tirzepatide typically running $129 to $258 per month. Watch for two things: introductory rates that rise after the first month, and dose-based price increases during titration. Programs with flat or locked pricing are more predictable over a full course of treatment.
Appetite generally returns toward baseline, and studies show most people regain a substantial portion of the weight within a year of stopping. That's why clinicians treat obesity as a chronic condition — a maintenance plan, whether a lower ongoing dose or a structured lifestyle program, matters as much as the initial loss.
Some platforms offer both. Shed provides brand-name and compounded options on one platform, and Ro offers the FDA-approved oral Wegovy pill. Most of the lower-priced programs on this list prescribe compounded medication only, which is how they reach price points far below brand-name list prices.
Yes — the medication makes it dramatically easier to eat less, but nutrition and resistance training determine the quality of the weight you lose. Adequate protein and strength work help preserve muscle while the scale drops, which protects your metabolism and long-term results.
GLP-1 treatment starts low and titrates upward over several months, and higher doses use more medication. Some programs pass that cost on, so your monthly bill climbs as your dose does. Others — including TrimRx, Wellmedr, and altRx on this list — advertise flat or locked pricing at every dose, which makes total cost easier to predict.
This article is for general information and is not a substitute for professional medical advice.
